New York City Medical Oncologist and Professor to be Honored for Lifetime Scientific Achievement

Wednesday, August 21, 2019

ProposalMasthead_0318-01-3.png


Contact:
Becky.Bunn@IASLC.org | 720-325-2946

Chris Martin
Cmartin@davidjamesgroup.com | 630.670.2745

New York City Medical Oncologist and Professor to be Honored for Lifetime Scientific Achievement

DENVER – Charles Rudin, MD, PhD, will be recognized by the International Association for the Study of Lung Cancer (IASLC) with the Paul A. Bunn, Jr. Scientific Award at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain. The award recognizes Dr. Rudin’s lifetime achievement in scientific contributions to thoracic cancer research.

Dr. Rudin is the Sylvia Hassenfeld Professor and chief of Thoracic Oncology at Memorial Sloan Kettering Cancer Center (MSKCC), where he also co-directs the Druckenmiller Center for Lung Cancer Research. At MSKCC he oversees a broad and integrated program of preclinical and clinical research in lung cancer.

Dr. Rudin has an interest in small cell lung cancer (SCLC) and chairs the National Cancer Institute’s SCLC Research Consortium, a national network of investigators studying SCLC oncogenesis, mouse and human preclinical modeling, genomic and epigenetic drivers and therapeutic vulnerabilities. He also serves as the MSK Primary Investigator for two Stand Up to Cancer (SU2C) grants.

Dr. Rudin will be honored on Sept. 7, 2019 at the Opening Ceremony of the IASLC 2019 WCLC in Barcelona, Spain. The IASLC WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The IASLC 2019 WCLC will take place in Barcelona, Spain, Sept. 7-10, 2019. For more information on the IASLC 2019 WCLC, please visit https://wclc2019.iaslc.org/

About the WCLC:

The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. 

###


About the Author

Chris Martin, Vice President, Public Relations